Stonebridge Capital Management Inc. purchased a new position in CME Group Inc. (NASDAQ:CME) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 1,000 shares of the financial services provider’s stock, valued at approximately $204,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Paces Ferry Wealth Advisors LLC purchased a new stake in shares of CME Group during the third quarter valued at $33,000. HHM Wealth Advisors LLC lifted its position in CME Group by 624.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 181 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 156 shares during the period. TCTC Holdings LLC acquired a new position in CME Group during the fourth quarter valued at $33,000. Merrion Investment Management Co LLC acquired a new position in CME Group during the fourth quarter valued at $35,000. Finally, Baron Silver Stevens Financial Advisors LLC acquired a new position in CME Group during the fourth quarter valued at $37,000. 83.88% of the stock is currently owned by hedge funds and other institutional investors.
CME stock traded down $1.48 during trading on Thursday, hitting $202.86. The stock had a trading volume of 12,461 shares, compared to its average volume of 1,815,949. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a twelve month low of $146.89 and a twelve month high of $216.75. The stock has a market capitalization of $72.83 billion, a P/E ratio of 34.06 and a beta of 0.46. The company’s 50-day moving average price is $204.38 and its two-hundred day moving average price is $182.89.
The firm also recently announced a quarterly dividend, which was paid on Thursday, March 25th. Shareholders of record on Wednesday, March 10th were paid a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 1.77%. This is a positive change from CME Group’s previous quarterly dividend of $0.85. The ex-dividend date of this dividend was Tuesday, March 9th. CME Group’s dividend payout ratio (DPR) is 52.94%.
In other CME Group news, insider Kevin Kometer sold 8,000 shares of the firm’s stock in a transaction that occurred on Friday, February 19th. The shares were sold at an average price of $195.75, for a total value of $1,566,000.00. Following the transaction, the insider now directly owns 76,688 shares of the company’s stock, valued at approximately $15,011,676. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Hilda Harris Piell sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, March 5th. The stock was sold at an average price of $213.00, for a total transaction of $319,500.00. Following the completion of the transaction, the insider now directly owns 36,704 shares in the company, valued at $7,817,952. The disclosure for this sale can be found here. Insiders sold a total of 23,000 shares of company stock worth $4,528,390 over the last three months. Corporate insiders own 1.20% of the company’s stock.
A number of research firms recently issued reports on CME. Barclays boosted their target price on shares of CME Group from $200.00 to $215.00 and gave the company an “overweight” rating in a research report on Tuesday, January 12th. Deutsche Bank Aktiengesellschaft downgraded shares of CME Group from a “buy” rating to a “hold” rating and set a $196.00 target price for the company. in a research report on Friday, January 8th. They noted that the move was a valuation call. Keefe, Bruyette & Woods upgraded shares of CME Group from an “underperform” rating to a “market perform” rating and boosted their target price for the company from $181.00 to $197.00 in a research report on Monday, March 1st. Zacks Investment Research downgraded shares of CME Group from a “buy” rating to a “hold” rating and set a $205.00 target price for the company. in a research report on Thursday, January 7th. Finally, Wells Fargo & Company upgraded shares of CME Group from an “equal weight” rating to an “overweight” rating and set a $230.00 price objective for the company in a research report on Wednesday, March 3rd. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and six have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $194.38.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions.
Recommended Story: What is meant by a buy rating?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.